The contact activation system: biochemistry and interactions of these surface-mediated defense reactions (Q39780188)

14 September 2017

title

The contact activation system: biochemistry and interactions of these surface-mediated defense reactions (English)

1 reference

14 September 2017

Colman RW

1

1 reference

14 September 2017

Schmaier AH

series ordinal

2

1 reference

14 September 2017

publication date

1 January 1986

1 reference

Critical Reviews in Oncology Hematology

14 September 2017

published in

1 reference

14 September 2017

volume

5

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

57-85

1 reference

The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Activation of plasminogen by human plasma kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

A comparision of the abilities of plasma kallikrein, β-factor XIIa, factor XIa and urokinase to activate plasminogen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Mechanisms of activation of the classical pathway of complement by Hageman factor fragment

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Linking the kallikrein and renin systems via activation of inactive renin: new data and a hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Purified human plasma kallikrein aggregates human blood neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Human factor XII (Hageman factor)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Structural changes accompanying enzymatic activation of human Hageman factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

The interrelationship of coagulation of plasma and release of peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Activation of Hagemen Factor by saturated fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Activation of Factors XII (Hageman) and XI (PTA) by Skin Contact

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Activation of Hageman Factor by L-Homocystine

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Studies on the interaction between collagen and a plasma kallikrein-like activity. Evidence for a surface-active enzyme system

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Aggregation of platelets by collagen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Mechanism of activation of bovine factor XI by factor XII and factor XIIa

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Activation of bovine factor XII (Hageman factor) by plasma kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

The autoactivation of rabbit Hageman factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Autoactivatability of human Hageman factor (factor XII)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Kinetics of activation and autoactivation of human factor XII.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Surface activation of blood coagulation, fibrinolysis and kinin formation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Molecular assembly in the contact phase of the Hageman factor system

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

The relationship of structure and function in human Hageman factor. The association of enzymatic and binding activities with separate regions of the molecule

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Immunochemical studies of plasma kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Human Plasma Prekallikrein: a Rapid High-Yield Method for Purification

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

The isolation of human plasma prekallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Plasma prekallikrein: isolation, characterization, and mechanism of activation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Contribution of Plasma Protease Inhibitors to the Inactivation of Kallikrein in Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Inactivation of kallikrein in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Hereditary angioneurotic edema. II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Interaction of human plasma kallikrein and its light chain with C1 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Antithrombin-heparin cofactor: an inhibitor of plasma kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Inhibitory spectrum of alpha 2-plasmin inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Substrates of Hageman factor. I. Isolation and characterization of human factor XI (PTA) and inhibition of the activated enzyme by alpha 1-antitrypsin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Activation of human factor XI (plasma thromboplastin antecedent) by factor XIIa (activated Hageman factor)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Potentiation of the function of Hageman factor fragments by high molecular weight kininogen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Preparation, characterization, and activation of a highly purified factor XI: evidence that a hitherto unrecognized plasma activity participates in the interaction of factors XI and XII

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Association of factor XI and high molecular weight kininogen in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Effect of intermediates of extrinsic clotting on purified factor XI: Factor VII and/or thromboplastin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Flaujeac trait. Deficiency of human plasma kininogen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Fitzgerald Trait: Deficiency of a Hitherto Unrecognized Agent, Fitzgerald Factor, Participating in Surface-Mediated Reactions of Clotting, Fibrinolysis, Generation of Kinins, and the Property of Diluted Plasma Enhancing Vascular Permeability (PF/Dil

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

High-molecular weight kininogen. A secreted platelet protein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Purification and properties of human low molecular weight kininogen.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Rapid purification of human high molecular weight kininogen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Flaujeac factor deficiency. Reconstitution with highly purified bovine high molecular weight-kininogen and delineation of a new permeability-enhancing peptide released by plasma kallikrein from bovine high molecular weight-kininogen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Bovine plasma HMW and LMW kininogens. Structural differences between heavy and light chains derived from the kinin-free proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Homology between bovine high molecular weight and low molecular weight kininogens

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Characterization of human high molecular weight kininogen. Procoagulant activity associated with the light chain of kinin-free high molecular weight kininogen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Studies on Human High Molecular Weight (HMW) Kininogen. II. Structural Change of HMW Kininogen by the Action of Human Plasma Kallikrein1

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

The accelerating effect of bovine plasma HMW kininogen on the surface-mediated activation of factor XII: generation of a derivative form (active kininogen) with maximal cofactor activity by limited proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Functional sites of bovine high molecular weight kininogen as a cofactor in kaolin-mediated activation of factor XII (Hageman factor).

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Role of surface in surface-dependent activation of Hageman factor (blood coagulation Factor XII)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

The mechanism by which the light chain of cleaved HMW-kininogen augments the activation of prekallikrein, factor XI and Hageman factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Second Kininase in Human Blood Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Angiotensin-Converting Enzyme and the Regulation of Vasoactive Peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Initiation of plasma prorenin activation by Hageman factor-dependent conversion of plasma prekallikrein to kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

An intrinsic factor XII- prekallikrein-dependent pathway activates the human plasma renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Plasma kallikrein-mediated activation of the renin-angiotensin system does not require prior acidification of prorenin.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

The effect of glass upon the activity of the various plasma clotting factors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

The Skin Window as a Monitor of Leukocytic Functions in Contact Activation Factor Deficiencies in Man

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Influence of augmented Hageman factor (Factor XII) titers on the cryoactivation of plasma prorenin in women using oral contraceptive agents

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

The conversion of C'IS to C'1 esterase by plasmin and trypsin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Activation of the classical pathway of complement by Hageman factor fragment

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Mechanisms of activation of C'1 esterase in hereditary angioneurotic edema plasma in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

The Role of Platelets in the Contact Phase of Blood Coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

The effects of collagen and kaolin on the intrinsic coagulant activity of platelets. Evidence for an alternative pathway in intrinsic coagulation not requiring factor XII

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Platelet C1- inhibitor. A secreted alpha-granule protein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Chemotactic activity generated from the fifth component of complement by plasma kallikrein of the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Leukocyte elastase release during blood coagulation. A potential mechanism for activation of the alternative fibrinolytic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Human plasma kallikrein releases neutrophil elastase during blood coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Effect of bradykinin and thrombin on prostacyclin synthesis in endothelial cells from calf and pig aorta and human umbilical cord vein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Bradykinin-induced release of prostacyclin and thromboxanes from bovine pulmonary artery endothelial cells. Studies with lower homologs and calcium antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Hageman Factor (Factor XII) in an Affected Kindred and in Normal Adults

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Repair of cardiac defect in patient with Ehlers-Danlos syndrome and deficiency of Hageman factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Myocardial infarction in a patient with a hageman (factor XII) defect

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Myocardial infarction associated with severe factor-XII deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Reduced Titers of Hageman Factor (Factor XII) in Orientals

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Isolation and properties of an abnormal Hageman factor (Factor XII) molecule in a cross-reacting material-positive hageman trait plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Fletcher Factor Deficiency: A Report of Three Unrelated Cases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Fletcher factor deficiency and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Prekallikrein deficiency in man

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Heterogeneity of human prekallikrein deficiency (Fletcher trait): evidence that five of 18 cases are positive for cross-reacting material

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Clinical and physiologic studies of two siblings with prekallikrein (Fletcher factor) deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Heredity and Coagulation Studies in Ten Families with Factor XI (Plasma Thromboplastin Antecedent) Deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Formation of Human Plasma Kinin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Partial purification and characterization of contact activation cofactor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Abnormalities in the contact activation through factor XII in Fujiwara trait: a deficiency in both high and low molecular weight kininogens with low level of prekallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

A single gene for bovine high molecular weight and low molecular weight kininogens

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Permeability-increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Plasma kinin activation in tranexamic acid treated patients with hereditary angioneurotic edema

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Detection of active kallikrein in induced blister fluids of hereditary angioedema patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of “spontaneous” formation of bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Replacement therapy in hereditary angioedema. Successful treatment of two patients with fresh frozen plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Hereditary angioedema: an appraisal of 104 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Tranexamic Acid Therapy in Hereditary Angioneurotic Edema

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Methyltestosterone Therapy in Hereditary Angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Response of variant hereditary angioedema phenotypes to danazol therapy. Genetic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Long-term therapy of hereditary angioedema with danazol.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Hereditary angioedema: The use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

A rapid pH Stat assay for plasma prekallikrein and fluctuations in disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Kallikrein-Bradykinin System in Chronic Alcoholic Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Prekallikrein and Kallikrein Inhibitor in Liver Cirrhosis and Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

EFFECTS OF BRADYKININ ON FOREARM VENOUS TONE AND VASCULAR RESISTANCE IN MAN

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Contribution of kinins to endotoxin shock in unanesthetized Rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Kinins — Possible Physiologic and Pathologic Roles in Man

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Plasma Kallikrein and Hageman Factor in Gram-Negative Bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Kinin system responses in sepsis after trauma in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Endotoxin, prekallikrein, complement and systemic vascular resistance. Sequential measurements in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Kallikrein-Kinin System in Postgastrectomy Dumping Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

RELEASE OF A KININ PEPTIDE IN THE CARCINOID SYNDROME

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Elevation in plasma kallikrein activity after rat kidney allografting

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Intravascular coagulation in hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Platelet function in hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Effect of clofibrate on intravascular coagulation in hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Clofibrate reversal of platelet hypersensitivity in hyperbetalipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

A kininogen-like substance in unheated human plasma proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Some components of the kinin system in Cohn's unheated human plasma proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Hypotension associated with prekallikrein activator (Hageman-factor fragments) in plasma protein fraction

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Plasma kallikrein activation and inhibition during typhoid fever

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Deficiency of Hageman factor (factor XII) in patients with the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Activation of hageman factor in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

A Study of the Plasma Kinin-generating System in Children with the Minimal Lesion, Idiopathic Nephrotic Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Receptors for high molecular weight kininogen on stimulated washed human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Deficiency and urinary losses of factor XII in adult nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Activation of the Kallikrein-Kinin System in Rocky Mountain Spotted Fever

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Kininogen and kallikrein in saliva of periodontally-diseased subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Circulating Anticoagulants Against Factors IX and XI in Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

Immunologic and Coagulation Disorders in Chlorpromazine-Treated Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2886%2980053-1

7 January 2021

10.1016/S1040-8428(86)80053-1

Identifiers

DOI

1 reference

14 September 2017

1 reference